These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 26159838)

  • 21. Diclofenac/biodegradable polymer micelles for ocular applications.
    Li X; Zhang Z; Li J; Sun S; Weng Y; Chen H
    Nanoscale; 2012 Aug; 4(15):4667-73. PubMed ID: 22732776
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risperidone solid dispersion for orally disintegrating tablet: its formulation design and non-destructive methods of evaluation.
    Rahman Z; Zidan AS; Khan MA
    Int J Pharm; 2010 Nov; 400(1-2):49-58. PubMed ID: 20801200
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microsphere delivery of Risperidone as an alternative to combination therapy.
    D'Souza S; Faraj J; DeLuca P
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):631-9. PubMed ID: 23892159
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel biodegradable blend matrices for controlled drug release.
    Lin M; Meng S; Zhong W; Li Z; Du Q; Tomasik P
    J Pharm Sci; 2008 Oct; 97(10):4240-8. PubMed ID: 18271038
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Formulation optimization of solid dispersion of mosapride hydrochloride.
    Kim HJ; Lee SH; Lim EA; Kim JS
    Arch Pharm Res; 2011 Sep; 34(9):1467-75. PubMed ID: 21975808
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sucrose acetate isobutyrate as an in situ forming system for sustained risperidone release.
    Lu Y; Yu Y; Tang X
    J Pharm Sci; 2007 Dec; 96(12):3252-62. PubMed ID: 17721936
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Investigation of PLLA/PCL blends and paclitaxel release profiles.
    Can E; Udenir G; Kanneci AI; Kose G; Bucak S
    AAPS PharmSciTech; 2011 Dec; 12(4):1442-53. PubMed ID: 22038476
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Poly(3-hydroxybutyrate-co-3-hydroxyvalerate)/poly(epsilon-caprolactone) blends for tissue engineering applications in the form of hollow fibers.
    Chiono V; Ciardelli G; Vozzi G; Sotgiu MG; Vinci B; Domenici C; Giusti P
    J Biomed Mater Res A; 2008 Jun; 85(4):938-53. PubMed ID: 17896770
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preparation and characterization of silk fibroin hydrogel as injectable implants for sustained release of Risperidone.
    Ebrahimi A; Sadrjavadi K; Hajialyani M; Shokoohinia Y; Fattahi A
    Drug Dev Ind Pharm; 2018 Feb; 44(2):199-205. PubMed ID: 28956466
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-lasting anti-platelet activity of cilostazol from poly(ε-caprolactone)-poly(ethylene glycol) blend nanocapsules.
    Gomes MLS; da Silva Nascimento N; Borsato DM; Pretes AP; Nadal JM; Novatski A; Gomes RZ; Fernandes D; Farago PV; Zanin SMW
    Mater Sci Eng C Mater Biol Appl; 2019 Jan; 94():694-702. PubMed ID: 30423756
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Melt electrospinning vs. solution electrospinning: A comparative study of drug-loaded poly (ε-caprolactone) fibres.
    Lian H; Meng Z
    Mater Sci Eng C Mater Biol Appl; 2017 May; 74():117-123. PubMed ID: 28254275
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhanced dissolution and bioavailability of grapefruit flavonoid Naringenin by solid dispersion utilizing fourth generation carrier.
    Khan AW; Kotta S; Ansari SH; Sharma RK; Ali J
    Drug Dev Ind Pharm; 2015 May; 41(5):772-9. PubMed ID: 24669978
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel biodegradable polyesters. Synthesis and application as drug carriers for the preparation of raloxifene HCl loaded nanoparticles.
    Bikiaris D; Karavelidis V; Karavas E
    Molecules; 2009 Jul; 14(7):2410-30. PubMed ID: 19633613
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Application of PVP/HPMC miscible blends with enhanced mucoadhesive properties for adjusting drug release in predictable pulsatile chronotherapeutics.
    Karavas E; Georgarakis E; Bikiaris D
    Eur J Pharm Biopharm; 2006 Aug; 64(1):115-26. PubMed ID: 16675210
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protein release from electrospun nonwovens: improving the release characteristics through rational combination of polyester blend matrices with polidocanol.
    Puhl S; Ilko D; Li L; Holzgrabe U; Meinel L; Germershaus O
    Int J Pharm; 2014 Dec; 477(1-2):273-81. PubMed ID: 25445519
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Physicochemical characterization of solid dispersions of three antiepileptic drugs prepared by solvent evaporation method.
    Douroumis D; Bouropoulos N; Fahr A
    J Pharm Pharmacol; 2007 May; 59(5):645-53. PubMed ID: 17524229
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effervescent tablet formulation for enhanced patient compliance and the therapeutic effect of risperidone.
    Mohammed KA; Ibrahim HK; Ghorab MM
    Drug Deliv; 2016; 23(1):297-306. PubMed ID: 24833273
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhancement of bio-compatibility via specific interactions in polyesters modified with a bio-resourceful macromolecular ester containing polyphenol groups.
    Yen KC; Mandal TK; Woo EM
    J Biomed Mater Res A; 2008 Sep; 86(3):701-12. PubMed ID: 18041717
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preparation and characterization of poly(epsilon-caprolactone) polymer blends for the delivery of proteins.
    Huatan H; Collett JH; Attwood D; Booth C
    Biomaterials; 1995 Nov; 16(17):1297-303. PubMed ID: 8573667
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of oral solid self-emulsifying lipid formulations of risperidone with improved in vitro dissolution and digestion.
    Kazi M; Al-Qarni H; Alanazi FK
    Eur J Pharm Biopharm; 2017 May; 114():239-249. PubMed ID: 28159721
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.